[Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Prophylaxie des infections post-allogreffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Anti-Bacterial Agents
/ therapeutic use
Antiviral Agents
Bacterial Infections
/ prevention & control
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation
/ adverse effects
Humans
Mycoses
/ prevention & control
Pneumocystis Infections
/ prevention & control
Postoperative Complications
/ prevention & control
Primary Prevention
/ methods
Secondary Prevention
/ methods
Societies, Medical
Toxoplasmosis
/ prevention & control
Transplantation, Homologous
/ adverse effects
Tuberculosis, Pulmonary
Virus Diseases
/ prevention & control
Allogeneic hematopoietic stem cell transplantation
Allogreffe de cellules souches hématopoïétiques
Complications infectieuses
Infectious complications
Prophylaxis
Traitements prophylactiques
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
14
05
2018
revised:
19
07
2018
accepted:
27
08
2018
pubmed:
9
1
2019
medline:
15
2
2019
entrez:
9
1
2019
Statut:
ppublish
Résumé
Allogeneic hematopoietic stem cell transplantation is a curative treatment for many hematological diseases. However, this procedure causes the patient to be susceptible to infection. Prophylactic treatments are administered in clinical practice even thought the level of evidence of their effectiveness is not always high. In addition, changes in the transplantation procedures - use of reduced intensity conditioning, development of alternative graft sources - must lead to a rethinking of attitudes towards prophylaxis. Our working group based its recommendations on a review of referential articles and publications on the subject found in the literature. These recommendations concern the prophylaxis of infections caused by HSV1, HSV2, varicella zoster, and hepatitis B, as well as anti-bacterial and digestive decontamination prophylaxis, prevention of pneumocystis, toxoplasmosis, tuberculosis, as well as prophylaxis of fungal infections. Other infectious agents usually involved in infections post-allotransplant have been the subject of another set of recommendations from the French Society of Bone Marrow Transplantation and Cellular Therapy.
Identifiants
pubmed: 30616839
pii: S0007-4551(18)30305-9
doi: 10.1016/j.bulcan.2018.08.017
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antiviral Agents
0
Types de publication
Consensus Development Conference
Journal Article
Practice Guideline
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
S23-S34Informations de copyright
Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.